Anteis
Innovative injectable medical devices for aesthetic enhancements, including wrinkle fillers and rehydration gels.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2015 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Merz Anteis SA is a leading global player in the development and manufacturing of biomedical products focused on aesthetics. The company specializes in creating injectable medical devices based on biopolymer transformation, which are used for various aesthetic enhancements such as wrinkle filling, resorbable implants, and cutaneous rehydration. Merz Anteis SA serves a diverse clientele that includes dermatologists, plastic surgeons, and aesthetic practitioners across over 90 countries on five continents. The company operates in the highly competitive aesthetic medicine market, where it differentiates itself through innovation and a comprehensive product portfolio. Merz Anteis SA's business model revolves around the research, development, and commercialization of advanced dermal fillers, which can be used individually or in combination to provide personalized aesthetic solutions. Revenue is generated through the sale of these specialized medical devices to healthcare professionals and clinics worldwide.
Keywords: biomedical products, aesthetics, injectable devices, wrinkle fillers, rehydration gels, biopolymer transformation, dermatologists, plastic surgeons, global market, innovative solutions.
